Literature DB >> 3142249

Stress ulcer prophylaxis in medical patients: who, what, and how much?

C M Wilcox1, J G Spenney.   

Abstract

Stress ulcers are a frequently encountered problem in critically ill medical patients. Gastric acid and decreased gastric mucosal blood flow appear to be important in the pathogenesis of these lesions. Occult bleeding from stress ulcers is common, although significant bleeding occurs in less than 20% of patients. The mortality of bleeding is dependent on the severity of the underlying diseases. A number of processes have been suggested as risk factors; however, prolonged mechanical ventilation, a coagulopathy, and the presence of more than one risk factor place the patient at greatest risk. Titration of the gastric pH to greater than four with either antacids or H2-receptor antagonists provides effective prophylaxis. The continuous infusion of the H2-receptor antagonists is also efficacious. Sucralfate appears to be another useful alternative with several potential advantages. Prophylactic therapy decreases the incidence of stress ulcer-related bleeding, although it does little to improve the survival of the critically ill patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142249

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

1.  Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates.

Authors:  A L Kuusela
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

2.  Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care.

Authors:  S Pitimana-aree; D Forrest; G Brown; A Anis; X H Wang; P Dodek
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.

Authors:  Gretchen M Brophy; Marcia L Brackbill; Katherine L Bidwell; Donald F Brophy
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

4.  Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.

Authors:  G T Schumock; N P Lam; S R Winkler; S X Kong
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

5.  Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?

Authors:  Abeer Zeitoun; Maya Zeineddine; Hani Dimassi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2011-08-06

Review 6.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

7.  Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury.

Authors:  P Burgess; G M Larson; P Davidson; J Brown; C A Metz
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

8.  Bleeding peptic ulcer occurring in hospitalized patients: analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage.

Authors:  S Loperfido; F Monica; L Maifreni; A Paccagnella; R Famà; R Dal Pos; C Sartori
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

9.  Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats.

Authors:  C Blandizzi; G Gherardi; G Natale; C Marveggio; M Del Tacca
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

10.  [Concept of stress ulcer prevention. Is re-thinking necessary?].

Authors:  S Kress; D Schilling; J F Riemann
Journal:  Med Klin (Munich)       Date:  1998-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.